Trevena Appoints Robert Prachar as Senior Vice President, Commercial and Corporate Strategy Apr 01, 2014 7:00am EDT
Trevena to Host Conference Call on March 20th to Discuss Full Year 2013 Financial Results and Recent Highlights Mar 13, 2014 4:16pm EDT
Trevena Initiates Clinical Development of TRV734, a Novel Biased Ligand for Moderate to Severe Pain Feb 05, 2014 7:00am EST
Trevena Announces Pricing of Initial Public Offering of 9,250,000 Shares of Common Stock Jan 31, 2014 6:30am EST
